153 related articles for article (PubMed ID: 28938487)
21. Somatostatin inhibits insulin release via SSTR2 in hamster clonal beta-cells and pancreatic islets.
Yao CY; Gill M; Martens CA; Coy DH; Hsu WH
Regul Pept; 2005 Jul; 129(1-3):79-84. PubMed ID: 15927701
[TBL] [Abstract][Full Text] [Related]
22. Insulinotropic glucagon-like peptide I receptor expression in glucagon-producing alpha-cells of the rat endocrine pancreas.
Heller RS; Kieffer TJ; Habener JF
Diabetes; 1997 May; 46(5):785-91. PubMed ID: 9133545
[TBL] [Abstract][Full Text] [Related]
23. Enhanced GLP-1- and sulfonylurea-induced insulin secretion in islets lacking leptin signaling.
Morioka T; Dishinger JF; Reid KR; Liew CW; Zhang T; Inaba M; Kennedy RT; Kulkarni RN
Mol Endocrinol; 2012 Jun; 26(6):967-76. PubMed ID: 22474124
[TBL] [Abstract][Full Text] [Related]
24. Engineered beta-cells secreting dipeptidyl peptidase IV-resistant glucagon-like peptide-1 show enhanced glucose-responsiveness.
Islam MS; Rahman SA; Mirzaei Z; Islam KB
Life Sci; 2005 Jan; 76(11):1239-48. PubMed ID: 15642594
[TBL] [Abstract][Full Text] [Related]
25. SSTR5 ablation in islet results in alterations in glucose homeostasis in mice.
Wang XP; Yang J; Norman MA; Magnusson J; DeMayo FJ; Brunicardi FC
FEBS Lett; 2005 Jun; 579(14):3107-14. PubMed ID: 15919085
[TBL] [Abstract][Full Text] [Related]
26. Somatostatin secreted by islet delta-cells fulfills multiple roles as a paracrine regulator of islet function.
Hauge-Evans AC; King AJ; Carmignac D; Richardson CC; Robinson IC; Low MJ; Christie MR; Persaud SJ; Jones PM
Diabetes; 2009 Feb; 58(2):403-11. PubMed ID: 18984743
[TBL] [Abstract][Full Text] [Related]
27. Glucagon-like peptide-1 stimulates insulin secretion by a Ca2+-independent mechanism in Zucker diabetic fatty rat islets of Langerhans.
Sreenan SK; Mittal AA; Dralyuk F; Pugh WL; Polonsky KS; Roe MW
Metabolism; 2000 Dec; 49(12):1579-87. PubMed ID: 11145120
[TBL] [Abstract][Full Text] [Related]
28. The multifaceted potential of glucagon-like peptide-1 as a therapeutic agent.
Lam NT; Kieffer TJ
Minerva Endocrinol; 2002 Jun; 27(2):79-93. PubMed ID: 11961501
[TBL] [Abstract][Full Text] [Related]
29. Glucagon-Like Peptide 1 Analogs and their Effects on Pancreatic Islets.
Tudurí E; López M; Diéguez C; Nadal A; Nogueiras R
Trends Endocrinol Metab; 2016 May; 27(5):304-318. PubMed ID: 27062006
[TBL] [Abstract][Full Text] [Related]
30. PEGylated glucagon-like peptide-1 displays preserved effects on insulin release in isolated pancreatic islets and improved biological activity in db/db mice.
Lee S; Youn YS; Lee SH; Byun Y; Lee KC
Diabetologia; 2006 Jul; 49(7):1608-11. PubMed ID: 16586064
[TBL] [Abstract][Full Text] [Related]
31. Activation of FFA1 mediates GLP-1 secretion in mice. Evidence for allosterism at FFA1.
Xiong Y; Swaminath G; Cao Q; Yang L; Guo Q; Salomonis H; Lu J; Houze JB; Dransfield PJ; Wang Y; Liu JJ; Wong S; Schwandner R; Steger F; Baribault H; Liu L; Coberly S; Miao L; Zhang J; Lin DC; Schwarz M
Mol Cell Endocrinol; 2013 Apr; 369(1-2):119-29. PubMed ID: 23403053
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, bioactivity and specificity of glucagon-like peptide-1 (7-37)/polymer conjugate to isolated rat islets.
Kim S; Wan Kim S; Bae YH
Biomaterials; 2005 Jun; 26(17):3597-606. PubMed ID: 15621250
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, characterization, and pharmacokinetic studies of PEGylated glucagon-like peptide-1.
Lee SH; Lee S; Youn YS; Na DH; Chae SY; Byun Y; Lee KC
Bioconjug Chem; 2005; 16(2):377-82. PubMed ID: 15769092
[TBL] [Abstract][Full Text] [Related]
34. Ezetimibe stimulates intestinal glucagon-like peptide 1 secretion via the MEK/ERK pathway rather than dipeptidyl peptidase 4 inhibition.
Chang E; Kim L; Choi JM; Park SE; Rhee EJ; Lee WY; Oh KW; Park SW; Park DI; Park CY
Metabolism; 2015 May; 64(5):633-41. PubMed ID: 25704082
[TBL] [Abstract][Full Text] [Related]
35. Intestinal Sodium Glucose Cotransporter 1 Inhibition Enhances Glucagon-Like Peptide-1 Secretion in Normal and Diabetic Rodents.
Oguma T; Nakayama K; Kuriyama C; Matsushita Y; Yoshida K; Hikida K; Obokata N; Tsuda-Tsukimoto M; Saito A; Arakawa K; Ueta K; Shiotani M
J Pharmacol Exp Ther; 2015 Sep; 354(3):279-89. PubMed ID: 26105952
[TBL] [Abstract][Full Text] [Related]
36. Intra-islet regulation of hormone secretion by glucagon-like peptide-1-(7--36) amide.
Heller RS; Aponte GW
Am J Physiol; 1995 Dec; 269(6 Pt 1):G852-60. PubMed ID: 8572216
[TBL] [Abstract][Full Text] [Related]
37. The entero-insular axis: implications for human metabolism.
Ranganath LR
Clin Chem Lab Med; 2008; 46(1):43-56. PubMed ID: 18020966
[TBL] [Abstract][Full Text] [Related]
38. Encapsulation of pancreatic islets within nano-thin functional polyethylene glycol coatings for enhanced insulin secretion.
Kizilel S; Scavone A; Liu X; Nothias JM; Ostrega D; Witkowski P; Millis M
Tissue Eng Part A; 2010 Jul; 16(7):2217-28. PubMed ID: 20163204
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of human pancreatic islet insulin release by receptor-selective somatostatin analogs directed to somatostatin receptor subtype 5.
Zambre Y; Ling Z; Chen MC; Hou X; Woon CW; Culler M; Taylor JE; Coy DH; Van Schravendijk C; Schuit F; Pipeleers DG; Eizirik DL
Biochem Pharmacol; 1999 May; 57(10):1159-64. PubMed ID: 11230804
[TBL] [Abstract][Full Text] [Related]
40. Glucose-dependent insulinotropic polypeptide is expressed in pancreatic islet alpha-cells and promotes insulin secretion.
Fujita Y; Wideman RD; Asadi A; Yang GK; Baker R; Webber T; Zhang T; Wang R; Ao Z; Warnock GL; Kwok YN; Kieffer TJ
Gastroenterology; 2010 May; 138(5):1966-75. PubMed ID: 20138041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
